| Patient | Arthur Ashe |
|---|---|
| Date of birth | 1943-07-10 |
| Identifiers | MRN HR-ML013-SYN-TD; SSN (made up) 000-13-6620 |
| Document date | 1989-02-09 |
| Author | Priyanka Rao, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
HIV infection diagnosed four months ago with cerebral toxoplasmosis and a CD4 count of 58, in a 45-year-old man who also has coronary artery disease after two bypass operations. Please review his antiretroviral regimen and its interactions with his cardiac medicines, and advise on opportunistic-infection prophylaxis, the monitoring schedule, and vaccines, so that we can co-manage his care. [S]
Urgency: Routine, within four weeks, on the same day as his four-week primary care visit. [S]
Questions for the consultant:
Mr. Ashe, a 45-year-old man, is seen at the request of Dr. Tolliver for co-management of HIV. HIV was diagnosed four months ago when he presented with right-hand weakness from cerebral toxoplasmosis, confirmed by stereotactic biopsy; the CD4 count was 58 and the viral load 186,000 copies/mL. He completed six weeks of pyrimethamine, sulfadiazine, and leucovorin and has taken trimethoprim-sulfamethoxazole double strength twice daily since. He started bictegravir, emtricitabine, and tenofovir alafenamide two weeks into toxoplasmosis treatment and has missed no doses. He has had no headache, seizure, fever, rash, or cough, and his right hand has recovered. He acquired HIV, he understands, from a blood transfusion during his second bypass operation; the hospital reported the suspected transfusion-transmitted infection to the blood supplier at diagnosis. He has coronary artery disease after two bypass operations and has no angina. He is clear that he alone decides who learns of his diagnosis. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium | One tablet by mouth once daily | Oral route | 1988-09-25 | active | S |
| Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intake | Three tablets by mouth daily after a 200 mg loading dose | Oral route | 1988-09-11 to 1988-10-23 | completed | S |
| Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intake | Three tablets by mouth every 6 hours | Oral route | 1988-09-11 to 1988-10-23 | completed | S |
| Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intake | Two tablets by mouth daily | Oral route | 1988-09-11 to 1988-10-23 | completed | S |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily | One tablet by mouth twice daily | Oral route | 1988-10-23 to 1989-10-19 | completed | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1979-07-31 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1979-08-01 | active | S |
| Ezetimibe 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1989-01-12 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 1979-08-01 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection | active | confirmed | B20 | S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled. |
| Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy | active | confirmed | B58.2 | S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass. |
| Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1942 and 1946 operations | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the history remains D. |
| Old myocardial infarction at age 36 | active | confirmed | I25.2 | S — Synthetic coded history of the documented 1979 heart attack. |
| Hyperlipidemia, on high-intensity statin | active | confirmed | E78.5 | S — Synthetic diagnosis; no cholesterol value from his lifetime is used. |
Vital signs recorded on 1989-02-09; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and composed; weight 72.6 kg; blood pressure 116/72 |
| Mouth | No thrush or oral hairy leukoplakia |
| Lymph nodes | No enlarged nodes |
| Skin | No rash |
| Neurological | Grip strength and fine finger movements equal on both sides; no focal deficit |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1989-02-09 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1989-02-09 | Potassium [Moles/volume] in Serum or Plasma | 4.8 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1989-02-09 | Creatinine [Mass/volume] in Serum or Plasma | 1.16 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1989-02-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M | 79 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1989-02-09 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
Data reviewed: Hospital records, including the MRI, the biopsy report, the baseline genotype, and the hepatitis, tuberculosis, and Toxoplasma serologies. Dr. Tolliver's intake note four weeks ago, with the viral load (42 copies/mL), CD4 count (156), blood count, metabolic panel, ALT, lipid panel, and ECG. Today's metabolic panel, below. [S]